z-logo
open-access-imgOpen Access
A Tupaia paramyxovirus vector system for targeting and transgene expression
Author(s) -
Christine E. Engeland,
Sascha Bossow,
Andrew W. Hudacek,
Birgit Hoyler,
Judith M. Förster,
Rūta Veinalde,
Dirk Jäger,
Roberto Cattaneo,
Guy Ungerechts,
Christoph Springfeld
Publication year - 2017
Publication title -
journal of general virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.55
H-Index - 167
eISSN - 1465-2099
pISSN - 0022-1317
DOI - 10.1099/jgv.0.000887
Subject(s) - biology , virology , recombinant dna , vector (molecular biology) , transgene , neutralizing antibody , antibody , gene , viral vector , genetic enhancement , virus , genetics
Viruses from the diverse family of Paramyxoviridae include important pathogens and are applied in gene therapy and for cancer treatment. The Tupaia paramyxovirus (TPMV), isolated from the kidney of a tree shrew, does not infect human cells and neutralizing antibodies against other Paramyxoviridae do not cross-react with TPMV. Here, we present a vector system for de novo generation of infectious TPMV that allows for insertion of additional genes as well as targeting using antibody single-chain variable fragments. We show that the recombinant TPMV specifically infect cells expressing the targeted receptor and replicate in human cells. This vector system provides a valuable tool for both basic research and therapeutic applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom